SISI
Get informed when a big investor buys or sells
+ FollowOvervalued by 449.7% based on the discounted cash flow analysis.
| Market cap | $229.17 Million |
|---|---|
| Enterprise Value | $232.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5064.66 |
| Beta | -1.89 |
| Outstanding Shares | 313,892 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 23.81 |
| Enterprise Value to EBIT | -16.8 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.19 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Shineco, Inc. develops and markets biological health products. The Company focuses on utilizing engineering technologies and biotechnologies to produce Chinese herbal medicines, organic agricultural produce, and specialized textiles.